covid 19 News and Research

RSS

Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19

A team of researchers from the University of Oxford, the London School of Hygiene and Tropical Medicine and other institutions recently analyzed extensive data collected by NHS England to reveal any association between SARS-CoV-2 infection and cardiometabolic or respiratory events.

23 Feb 2021

How effective has Israel’s SARS-CoV-2 testing and vaccination campaign been against the UK variant?

A recent study by researchers at Tel Aviv University describes the UK variant’s rise to dominance in Israel. It also assesses the efficacy of the testing and vaccination programs employed by the government.

23 Feb 2021

L452R mutation potentially favors adaptive evolution of SARS-CoV-2

A team of scientists from the United States recently investigated the mutational signatures in the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein.

23 Feb 2021

mRNA Therapeutics – Analytical and Bioanalytical Characterization

NewsMed interviews Anette Bak from AstraZeneca about her research on developments in mRNA therapeutics that she will present at Pittcon 2021.

From Pittcon 23 Feb 2021

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

The study began with the generation of recombinant (r)SA11 rotaviruses, into which segment 7 modified RNAs were introduced. These encoded sequences for the non-structural protein NSP3 and some parts of the viral spike.

23 Feb 2021

Countries with older populations have higher SARS-CoV-2 infections and deaths, says study

A new study examines some patterns revealed by a study of the factors operating in different regions and countries, to offer plausible hypotheses of these variations.

23 Feb 2021

Intentional cooling of the body may help improve acute respiratory distress syndrome

A tenth of all intensive care unit patients worldwide, and many critical patients with COVID-19, have acute respiratory distress syndrome (ARDS). Therapeutic hypothermia, an intentional cooling of the body, has been suggested as a way to improve ARDS.

23 Feb 2021

Australia shows an increase in COVID-19 vaccine hesitancy, says study

A disturbing new study details an increase in vaccine hesitancy among many Australians over the period of August 2020 to January 2021. This may have serious implications for the country’s ability to achieve universal immunization.

23 Feb 2021

More diverse SARS-CoV-2 variants identified within infected children than in adults

A new study describes the identification of multiple circulating variants of SARS-CoV-2 during this early pandemic period from Asia and Europe. In addition, there were multiple local introductions of different variants, that resulted in multiple waves of transmission.

23 Feb 2021

What makes viruses infectious?

In this interview, News-Medical spoke to Professor Peter Stockley about his latest research that looked at what makes viruses infectious.

23 Feb 2021

Beckman Coulter Life Sciences established as first us distributor of genedrive plc COVID-19 kit

As the world continues to seek solutions in response to the coronavirus pandemic, Beckman Coulter Life Sciences announces it is the first United States distributor of the Genedrive® 96 SARS-CoV-2 kit. The agreement with the near-patient molecular diagnostics company, genedrive plc (LSE: GDR), is for distribution in the US and throughout Europe.

From Beckman Coulter Life Sciences - Flow Cytometry 23 Feb 2021

HSE researchers discover genetic predisposition to COVID-19 severity

HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology.

23 Feb 2021

Study: COVID-19 infection in pregnancy does not increase risk of stillbirth or neonatal death

COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death, according to a new study.

23 Feb 2021

Researchers investigate how CF patients respond to COVID-19

So far, based on clinical data, patients with cystic fibrosis (CF) don't appear to be especially susceptible to COVID-19, and when they do get infected, they don't seem to get sicker. But Ruobing (Ruby) Wang, MD, a physician-scientist in the Division of Pulmonary Medicine at Boston Children's Hospital, cares for patients with CF and thinks there is more to the story.

23 Feb 2021

Study examines the adoption of telemedicine program in a senior living community

With the onset of the COVID-19 pandemic, telemedicine has become a new norm for many routines and non-emergency medical needs.

23 Feb 2021

Protective COVID-19 antibodies can transfer from mothers to babies in the womb

Antibodies that guard against COVID-19 can transfer from mothers to babies while in the womb, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researchers published in the American Journal of Obstetrics and Gynecology.

23 Feb 2021

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.

23 Feb 2021

New study highlights 10 crucial lessons from the COVID-19 pandemic

A mixture of smaller countries led by New Zealand, Vietnam, Taiwan, Thailand, Cyprus, Rwanda and Iceland led the world 's Top 10 countries to manage their COVID-19 response well, according to a new study.

23 Feb 2021

People with absence of natural killer cell receptor are likely to develop severe COVID-19

The course and severity of COVID-19 in individual patients are largely influenced by the interaction between the SARS-CoV-2 coronavirus and the human immune system.

23 Feb 2021

Influenza A virus defective interfering particles against SARS-CoV-2

In the search for a broadly acting pan-specific antiviral, an interdisciplinary team from Germany tested the previously proposed (for antiviral treatment against Influenza A infections) - Influenza A virus (IAV) defective interfering particles (DIPs). The research is published online on the bioRxiv preprint server.

23 Feb 2021

covid 19 News and Research

Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19

How effective has Israel’s SARS-CoV-2 testing and vaccination campaign been against the UK variant?

L452R mutation potentially favors adaptive evolution of SARS-CoV-2

mRNA Therapeutics – Analytical and Bioanalytical Characterization

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Countries with older populations have higher SARS-CoV-2 infections and deaths, says study

Intentional cooling of the body may help improve acute respiratory distress syndrome

Australia shows an increase in COVID-19 vaccine hesitancy, says study

More diverse SARS-CoV-2 variants identified within infected children than in adults

What makes viruses infectious?

Beckman Coulter Life Sciences established as first us distributor of genedrive plc COVID-19 kit

HSE researchers discover genetic predisposition to COVID-19 severity

Study: COVID-19 infection in pregnancy does not increase risk of stillbirth or neonatal death

Researchers investigate how CF patients respond to COVID-19

Study examines the adoption of telemedicine program in a senior living community

Protective COVID-19 antibodies can transfer from mothers to babies in the womb

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

New study highlights 10 crucial lessons from the COVID-19 pandemic

People with absence of natural killer cell receptor are likely to develop severe COVID-19

Influenza A virus defective interfering particles against SARS-CoV-2

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News